Ferring Pharmaceuticals has informed the state that it will lay off 55 employees — all or most of the workers at its Roseville manufacturing, research and development plant.

The plant at 2660 Patton Road in Roseville is home to Rebiotix Inc, which was acquired by the Ferring Pharmaceuticals Group in 2018 and specializes in clinical-stage biotechnology for the treatment of gastrointestinal diseases.

Ferring, a Swiss-based multinational company with offices and plants in more than 120 countries, produces medicines for reproductive and maternal health, as well as the fields of gastroenterology and urology.

According to a WARN notice issued by the Minnesota Department of Employment and Economic Development’s rapid response team on Thursday, the 55 workers who will be permanently laid off on Feb. 5 include a manufacturing technician, quality control technician, marketing manager, stool donor engagement associate, senior materials and supply planner, microbiologist, project engineer and others.

A spokesman for DEED said it was unclear if the layoffs constituted a full plant closure. Calls and emails to Ferris were not immediately returned on Thursday.

The employees are non-unionized and do not have bumping rights, according to DEED.

Related Articles

Charges: Barber started Shoreview fire to get owner to move barbershop to Columbia Heights

Teen pleads guilty to role in St. Paul homicide that prompted ‘no knock’ warrant at Amir Locke’s apartment complex

Public meeting scheduled for Wednesday on two proposed specialty hospitals in St. Paul, Roseville

Woman who threw puppy during Ramsey County pursuit given probation, banned from owning animals

Man found dead in wreckage of South St. Paul house explosion was owner’s son, family says